PE20160123A1 - Metodos para mejorar la calidad de la composicion del meibo de las glandulas de meibomio - Google Patents
Metodos para mejorar la calidad de la composicion del meibo de las glandulas de meibomioInfo
- Publication number
- PE20160123A1 PE20160123A1 PE2015001987A PE2015001987A PE20160123A1 PE 20160123 A1 PE20160123 A1 PE 20160123A1 PE 2015001987 A PE2015001987 A PE 2015001987A PE 2015001987 A PE2015001987 A PE 2015001987A PE 20160123 A1 PE20160123 A1 PE 20160123A1
- Authority
- PE
- Peru
- Prior art keywords
- improve
- methods
- meibo
- meibomian glands
- quality
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invencion hace referencia a metodos para mejorar la capa lipidica de la lagrima e incrementar el tiempo de ruptura lagrimal por medio de la elevacion del indice de omega-3 en pacientes que sufren de los sintomas del ojo seco, blefaritis posterior y/o disfuncion de las glandulas de meibomio
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/815,599 US9381183B2 (en) | 2012-07-18 | 2013-03-12 | Methods for improving the quality of the meibum composition of meibomian glands |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20160123A1 true PE20160123A1 (es) | 2016-03-03 |
Family
ID=49947054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2015001987A PE20160123A1 (es) | 2013-03-12 | 2014-02-05 | Metodos para mejorar la calidad de la composicion del meibo de las glandulas de meibomio |
Country Status (10)
Country | Link |
---|---|
US (1) | US9381183B2 (es) |
EP (1) | EP2968243B1 (es) |
JP (2) | JP6538022B2 (es) |
KR (1) | KR101904850B1 (es) |
CN (1) | CN105358142A (es) |
CA (1) | CA2904737C (es) |
CL (1) | CL2015002713A1 (es) |
ES (1) | ES2743614T3 (es) |
PE (1) | PE20160123A1 (es) |
WO (1) | WO2014158356A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7981145B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience Inc. | Treatment of meibomian glands |
US8950405B2 (en) | 2006-05-15 | 2015-02-10 | Tearscience, Inc. | Treatment of obstructive disorders of the eye or eyelid |
WO2013003594A2 (en) | 2011-06-28 | 2013-01-03 | Tearscience, Inc. | Methods and systems for treating meibomian gland dysfunction using radio-frequency energy |
US20070060988A1 (en) | 2005-07-18 | 2007-03-15 | Grenon Stephen M | Melting meibomian gland obstructions |
US20090043365A1 (en) | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
US8915253B2 (en) | 2005-07-18 | 2014-12-23 | Tearscience, Inc. | Method and apparatus for treating gland dysfunction employing heated medium |
US20080114423A1 (en) | 2006-05-15 | 2008-05-15 | Grenon Stephen M | Apparatus for inner eyelid treatment of meibomian gland dysfunction |
US9314369B2 (en) | 2006-05-15 | 2016-04-19 | Tearscience, Inc. | System for inner eyelid treatment of meibomian gland dysfunction |
US10709680B2 (en) | 2011-07-18 | 2020-07-14 | Physicians Recommended Nutriceuticals, Llc | Methods for treating dry eye |
US9115078B2 (en) * | 2011-07-18 | 2015-08-25 | Physicians Recommended Nutriceuticals, Llc | Compositions for improving the quality of the meibum composition of inflamed or dysfunctional meibomian glands |
US20210121430A1 (en) | 2011-07-18 | 2021-04-29 | Prn Physician Recommended Nutriceuticals, Llc | Omega-3 fatty acid supplementation for use in treating dry eye |
MX2014002877A (es) | 2011-09-12 | 2014-09-12 | Tassos Georgiou | Uso de acidos grasos omega para el tratamiento de enfermedades. |
JP6324671B2 (ja) * | 2012-06-19 | 2018-05-16 | 参天製薬株式会社 | ヘアレス動物の眼瞼状態の変化方法 |
US10842670B2 (en) | 2012-08-22 | 2020-11-24 | Johnson & Johnson Vision Care, Inc. | Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices |
JP6497812B2 (ja) * | 2013-06-28 | 2019-04-10 | 学校法人慶應義塾 | マイボーム腺機能不全の処置剤 |
AU2015269353B2 (en) * | 2014-06-04 | 2020-03-26 | Tersus Pharmaceuticals, LLC | Methods of treating chronic dry eye disease using C16:1n7 palmitoleate and derivatives thereof |
WO2018005685A1 (en) * | 2016-06-29 | 2018-01-04 | Physicians Recommended Nutriceuticals, Llc | Compositions and methods for using same for reducing levels of arachidonic acid in tissue having undergone an invasive procedure |
CN108042522A (zh) * | 2017-12-29 | 2018-05-18 | 广东海洋大学 | 一种用于提高抗炎症功能的不饱和脂肪酸组合物及其应用 |
WO2021148845A1 (en) * | 2020-01-23 | 2021-07-29 | Visufarma S.P.A. | Ophthalmic composition for the treatment of dry eye disease |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI225398B (en) | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
MXPA02004703A (es) | 1999-11-09 | 2004-09-10 | Alcon Inc | Composiciones que contienen derivados de acido hidroxieicostetraenoico y metodos de uso para tratar trastornos de resequedad en los ojos. |
US6506412B2 (en) | 2000-11-29 | 2003-01-14 | Sciencebased Health | Treatment of dry eye syndrome |
US20060127505A1 (en) | 2002-01-16 | 2006-06-15 | David Haines | Anti-inflammatory formulations |
US20040076695A1 (en) * | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
US6649195B1 (en) | 2002-07-11 | 2003-11-18 | Vitacost.Com, Inc. | Eyesight enhanced maintenance composition |
US7041840B2 (en) | 2002-12-18 | 2006-05-09 | Alberta Research Council Inc. | Antioxidant triacylglycerols and lipid compositions |
US9192586B2 (en) | 2003-03-10 | 2015-11-24 | Zeavision Llc | Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders |
RU2007103835A (ru) * | 2004-07-01 | 2008-08-10 | Шепенс Ай Рисерч (Us) | Композиции и способы лечения заболеваний и нарушений состояния глаз |
US20070265341A1 (en) * | 2004-07-01 | 2007-11-15 | The Schepens Eye Research Institute Inc. | Compositions and methods for treating eye disorders and conditions |
US8541413B2 (en) | 2004-10-01 | 2013-09-24 | Ramscor, Inc. | Sustained release eye drop formulations |
DE202004015931U1 (de) | 2004-10-13 | 2005-01-05 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung |
EP1962618A2 (en) | 2005-12-20 | 2008-09-03 | Alcon Research, Ltd. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
WO2008143642A2 (en) | 2006-11-09 | 2008-11-27 | Children's Medical Center Corporation | Methods of treating and preventing ocular neovascularization with omega-3 polyunsaturated fatty acids |
EP1932520A1 (en) | 2006-12-15 | 2008-06-18 | Novartis AG | Nutritional supplement composition for treatment of ocular diseases |
EP1932521A1 (en) | 2006-12-15 | 2008-06-18 | Novartis AG | Nutritional supplement composition for treatment of ocular diseases |
US20090226547A1 (en) | 2008-03-05 | 2009-09-10 | Gilbard Jeffrey P | Dietary Supplement For Eye Health |
EP2349233A4 (en) | 2008-10-09 | 2012-04-18 | Waratah Pharmaceuticals Inc | USE OF SCYLLO-INOSITOLS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH MACULAR DEGENERATION |
IT1393419B1 (it) * | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
US20130011469A1 (en) | 2009-07-23 | 2013-01-10 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Krill oil and carotenoid composition, associated method and delivery system |
JP2013510095A (ja) * | 2009-11-06 | 2013-03-21 | アルコン リサーチ, リミテッド | ドライアイの軽減のための栄養サプリメント |
KR20120115380A (ko) * | 2010-01-11 | 2012-10-17 | 지티엑스, 인코포레이티드 | 마이봄선 기능 장애의 치료 방법 |
EP2641597A4 (en) * | 2010-11-19 | 2014-04-30 | Nippon Suisan Kaisha Ltd | THERAPEUTIC OR PROPHYLACTIC AGENT FOR CORNEAL EPITHELIUM DISORDERS AND / OR CONNECTIVE EPITHELIUM DISORDERS |
CA2738357C (en) | 2011-04-07 | 2019-08-06 | Amerisciences, Lp | Methods and compositions to promote ocular health |
-
2013
- 2013-03-12 US US13/815,599 patent/US9381183B2/en active Active
-
2014
- 2014-02-05 JP JP2016500204A patent/JP6538022B2/ja active Active
- 2014-02-05 ES ES14773402T patent/ES2743614T3/es active Active
- 2014-02-05 EP EP14773402.4A patent/EP2968243B1/en active Active
- 2014-02-05 KR KR1020157027914A patent/KR101904850B1/ko active IP Right Grant
- 2014-02-05 CA CA2904737A patent/CA2904737C/en active Active
- 2014-02-05 CN CN201480027112.4A patent/CN105358142A/zh active Pending
- 2014-02-05 WO PCT/US2014/014937 patent/WO2014158356A1/en active Application Filing
- 2014-02-05 PE PE2015001987A patent/PE20160123A1/es unknown
-
2015
- 2015-09-14 CL CL2015002713A patent/CL2015002713A1/es unknown
-
2019
- 2019-01-25 JP JP2019011316A patent/JP2019058194A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP6538022B2 (ja) | 2019-07-03 |
ES2743614T3 (es) | 2020-02-20 |
US20140024625A1 (en) | 2014-01-23 |
EP2968243A4 (en) | 2016-09-14 |
CL2015002713A1 (es) | 2016-09-30 |
JP2016512245A (ja) | 2016-04-25 |
KR101904850B1 (ko) | 2018-10-08 |
WO2014158356A1 (en) | 2014-10-02 |
EP2968243A1 (en) | 2016-01-20 |
US9381183B2 (en) | 2016-07-05 |
JP2019058194A (ja) | 2019-04-18 |
EP2968243B1 (en) | 2019-06-19 |
CA2904737C (en) | 2019-11-26 |
CA2904737A1 (en) | 2014-10-02 |
KR20150126405A (ko) | 2015-11-11 |
CN105358142A (zh) | 2016-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20160123A1 (es) | Metodos para mejorar la calidad de la composicion del meibo de las glandulas de meibomio | |
DOP2016000295A (es) | Compuestos y composiciones como agonistas del receptor tipo toll 7 | |
CO2017004525A2 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
CL2016001983A1 (es) | Compuestos aza bicíclicos como agonistas del receptor muscarínico m1 y/o m4 | |
ECSP19015192A (es) | Composiciones y métodos de inhibir masp-3 para el tratamiento de diversas enfermedades y trastornos | |
GT201600147A (es) | Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2 | |
ECSP18049420A (es) | Composiciones novedosas, usos y métodos para hacerlas | |
DOP2015000246A (es) | Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares | |
UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
BR112019006160A2 (pt) | composições e métodos para o tratamento das condições oftálmicas | |
UY37098A (es) | Moduladores de ror-gamma | |
CR20160561A (es) | Variantes del anticuerpo anti-factor d y sus usos | |
CR20150571A (es) | Compuestos y composiciones terapéuticos | |
CL2017001301A1 (es) | Composiciones oftálmicas estabilizadas de omega 3 | |
ECSP16078782A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
UY34545A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios. | |
ECSP14030779A (es) | Inhibidores del nampt | |
CL2018000597A1 (es) | Métodos para tratar enfermedades inflamatorias | |
UY32937A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119 | |
DOP2018000219A (es) | Anticuerpos anti-factor bb del complemento y usos de estos | |
DOP2016000212A (es) | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados | |
UY37038A (es) | Composiciones y métodos para disminuir la expresión de tau | |
UY34615A (es) | Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias. | |
CR20160290A (es) | Inhibidores tetracíclicos de autotaxina | |
CR20150653A (es) | Compuestos nuevos para el tratamiento del cáncer |